LRMR
Larimar Therapeutics, Inc.
+0.03 (+0.89%)3.97USD584K成交股數412M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 28.0M | 25.0M | 59.4M | 44.9M | 23.4M | 26.6M | 13.9M | 19.7M | 12.9M | 10.6M | 6.6M | 5.9M |
| 銷售管理費用 | 6.4M | 6.1M | 4.6M | 4.6M | 4.4M | 4.6M | 4.3M | 4.9M | 3.8M | 3.5M | 3.8M | 3.7M |
| 營業利益 | −34.4M+24% | −31.1M-0% | −64.0M+251% | −49.5M+101% | −27.8M+66% | −31.2M+120% | −18.3M+77% | −24.6M+156% | −16.7M | −14.2M | −10.3M | −9.6M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −32.8M+25% | −29.6M+1% | −62.5M+303% | −47.7M+121% | −26.2M+79% | −29.3M+125% | −15.5M+71% | −21.6M+159% | −14.7M | −13.0M | −9.1M | −8.4M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | – | – | – | -0.61+79% | -0.41+52% | -0.46+59% | -0.24+14% | -0.34+79% | -0.27 | -0.29 | -0.21 | -0.19 |
| 稀釋股數 | – | – | – | 78.3M | 64.0M | 64.0M | 63.8M | 63.8M | 53.6M | 43.9M | 43.9M | 43.9M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 92.7M | 178M | 85.4M | 90.1M | 20.6M | 21.1M | 35.1M | 32.3M | 110M | 26.7M | 38.7M | 94.3M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 165M | 209M | 146M | 187M | 150M | 170M | 219M | 237M | 248M | 95.9M | 104M | 112M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 37.9M | 50.5M | 67.8M | 48.3M | 30.1M | 25.9M | 20.6M | 25.8M | 17.4M | 14.2M | 11.2M | 11.8M |
| 股東權益 | 127M | 158M | 78.1M | 139M | 120M | 144M | 198M | 211M | 231M | 81.7M | 92.7M | 99.9M |
| 負債比 | 22.9% | 24.2% | 46.5% | 25.8% | 20.1% | 15.2% | 9.4% | 10.9% | 7.0% | 14.8% | 10.8% | 10.5% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −44.6M+68% | – | – | – | −26.5M | – | – | −10.4M | – | – | – |
| 資本支出 | – | – | – | – | – | 49K | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | −26.6M | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −166M | –% | – | −113M |
| FY2024 | – | – | −80.6M | –% | -1.32 | −71.3M |
| FY2023 | – | – | −36.9M | –% | -0.84 | −33.6M |
| FY2022 | – | – | −35.4M | –% | -1.37 | −27.7M |
| FY2021 | – | – | −50.6M | –% | -2.95 | −42.4M |
| FY2020 | – | – | −42.5M | –% | -3.57 | −42.3M |
| FY2019 | 0.00 | – | −23.1M | –% | -3.80 | −22.8M |
| FY2018 | 0.00 | – | −61.4M | –% | -1.90 | −51.6M |